返回ChemicalBook首页>CAS数据库列表>72873-74-6

72873-74-6

中文名称 6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
英文名称 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDINYL)IMIDAZO[2,1-B]THIAZOLE DIHYDROCHLORIDE
CAS 72873-74-6
分子式 C16H12FN3S
分子量 297.35
MOL 文件 72873-74-6.mol
更新日期 2023/10/26 17:11:16
72873-74-6 结构式 72873-74-6 结构式

基本信息

中文别名
6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
英文别名
CS-1711
SKF-86002
SKF 86002
SKF86002
SKF 86002 DIHYDROCHLORIDE
SKF-86002 - CAS 72873-74-6 - Calbiochem
6-(4-fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydroiMidazo[2,1-b]thi
5-(4-Pyridyl)-6-(4-fluorophenyl)-2,3-dihydroimidazo[2,1-b]thiazole
6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDYL)IMIDAZO[2,1-B]THIAZOLE
6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PRIDYL)IMIDAZO-[2,1,B]-THAIZOLE
6-(4-FLUOROPHENYL)-5-(4-PYRIDYL)-2,3-DIHYDROIMIDAZO[2,1-B]-THIAZOLE
所属类别
生物化工:激动剂抑制剂

物理化学性质

熔点189-190 °C(lit.)
沸点476.1±55.0 °C(Predicted)
密度1.39±0.1 g/cm3(Predicted)
储存条件Keep in dark place,Sealed in dry,2-8°C
溶解度DMSO: 9 mg/mL, soluble
酸度系数(pKa)4.36±0.10(Predicted)
形态solid
颜色off-white
InChIKeyYOELZIQOLWZLQC-UHFFFAOYSA-N

安全数据

6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/04/30HY-125116-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
SKF-86002
72873-74-62mg400元
2024/04/30HY-125116-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
SKF-86002
72873-74-65 mg810元
2024/04/30HY-125116-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
SKF-86002
72873-74-610mM * 1mLin DMSO891元

常见问题列表

生物活性
SKF-86002 是一种具有口服活性的 p38 MAPK 抑制剂,具有抗炎、抗关节炎和镇痛活性。SKF-86002 能抑制脂氧合酶和环氧合酶介导的花生四烯酸代谢。
体外研究

SKF-86002 (10 μM; 1 hour) inhibits apoptosis induced by stress stimulation with UV irradiation (UV).
SKF-86002 does not inhibit UV-induced apoptosis in undifferentiated HL-60 cells.
SKF-86002 (10 μM; 72 hours) prevent IL-4-induced monocyte or U937 cell CD23 surface expression and protein formation with no effect on CD23 mRNA levels.

Western Blot Analysis

Cell Line: U937 cells
Concentration: 10 μM
Incubation Time: 72 hours
Result: Significantly reduced CD23 levels on IL-4-treated U937 cells.
体内研究

SKF-86002 (10-90 mg/kg; p.o.; daily; for 22 days) has antiarthritic activity.

Animal Model: Lewis rats, with adjuvant-induced arthritis (AA)
Dosage: 10 mg/kg, 30 mg/kg, 90 mg/kg
Administration: Oral administration, daily, for 22 days
Result: Significantly decreased hindleg volumes after injection of adjuvant.
"72873-74-6" 相关产品信息
89402-43-7 110-86-1 52334-81-3